1. Home
  2. Health and social care
  3. Public health
  4. Health improvement

Drug misuse and dependency

On this page

Services

  1. NDTMS: community combined review forms

    Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.

  2. NDTMS: secure setting outcomes forms

    Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.

See more services in this topic

Guidance and regulation

  1. Controlled drugs list
    • Guidance
    • Home Office
  2. COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
    • Guidance
    • Department of Health and Social Care and Public Health England
  3. Drug misuse and dependence: UK guidelines on clinical management
    • Guidance
    • Department of Health and Social Care
  4. Independent review of drugs, part 2: terms of reference
    • Guidance
    • Department of Health and Social Care
  5. Precursor chemical licensing
    • Detailed guide
    • Home Office
See more guidance and regulation in this topic

News and communications

News story

New appointments to the ACMD

Advisory Council on the Misuse of Drugs

  1. Government launches second phase of independent review into drug misuse
    • Department of Health and Social Care
    • Press release
  2. ACMD public evidence gathering: request for written evidence
    • Advisory Council on the Misuse of Drugs
    • News story
  3. Circular 001/2020: Epidyolex scheduling, (SI) 2020 No. 559
    • Home Office
    • Correspondence
  4. ACMD advice on administration rights for therapeutic radiographer independent prescribers
    • Advisory Council on the Misuse of Drugs
    • Correspondence
See more news and communications in this topic

Research and statistics

  1. United Kingdom drug situation: Focal Point annual report
    • Home Office, Public Health England, Welsh Government, The Scottish Government, Public Health Wales, and Department of Health (Northern Ireland)
    • Research
  2. Novel benzodiazepines: prevalence and harms in the UK
    • Advisory Council on the Misuse of Drugs
    • Research
  3. Substance misuse treatment in secure settings: 2018 to 2019
    • Public Health England
    • Official statistics
  4. Shooting Up: infections among people who inject drugs in the UK
    • Public Health England
    • Research
  5. Substance misuse treatment for young people: statistics 2018 to 2019
    • Public Health England
    • National statistics
See more research and statistics in this topic

Policy papers and consultations

  1. Independent review of drugs: call for evidence, part 2
    • Department of Health and Social Care
    • Closed consultation
    • Date closed 07 August 2020
  2. NDTMS annual reports and methodology: proposed changes
    • Public Health England
    • Consultation outcome
    • Date closed 25 August 2019
  3. ACMD ageing cohort of drug users report: government response
    • Department of Health and Social Care
    • Policy paper
  4. Drug related harms in homeless populations: government response
    • Ministry of Housing, Communities & Local Government and Department of Health and Social Care
    • Policy paper
  5. Drugs policy and medicinal cannabis report: government response
    • Department of Health and Social Care
    • Policy paper
See more policy papers and consultations in this topic

Transparency and freedom of information releases

  1. Standard Operating Procedure for using evidence in ACMD reports
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  2. Commissioning impact on drug treatment
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  3. Drug strategy 2016: development review
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  4. Psychoactive Substances Bill: evaluation review
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  5. Methiopropamine: a review of the evidence of use and harm
    • Advisory Council on the Misuse of Drugs
    • Corporate report
See more transparency and freedom of information releases in this topic

Organisations

Show more organisations